Improvement in Sjögren's syndrome following therapy with rituximab for marginal zone lymphoma

Arthritis Care and Research

Volumn 49, Issue 3, 2003, Pages 394-398

  Somer, Bradley G ^a,b   Tsai, Donald E ^a   Downs, Lisa ^a   Weinstein, Barry ^a   Schuster, Stephen J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYCHLOROQUINE; RITUXIMAB;

ADULT; ARTICLE; ASPIRATION BIOPSY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; LYMPHOMA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; SJOEGREN SYNDROME; SUBMANDIBULAR GLAND; XEROPHTHALMIA; XEROSTOMIA;

EID: 0038651237     PISSN: 21514658     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.11109     Document Type: Article

References (15)

1. Moutsopoulos HM, Chused TM, Mann DL, Klippel JH, Fauci AS, Frank MM, et al. Sjögren's syndrome (sicca syndrome): current issues. Ann Intern Med 1980;92:212-26.
2. Kassan SS, Thomas TL, Moutsopoulos HM, Hoover R, Kimberly RP, Budman DR, et al. Increased risk of lymphoma in sicca syndrome. Ann Intern Med 1978;89:888-92.
3. Fox R. Epidemiology and pathogenesis of Sjögren's syndrome. Curr Opin Rheumatol 1994;6:501-8.
4. Brown SL, Miller RA, Horning SJ, Czerwinski D, Hart SM, McElderry R, et al. Treatment of B-cell lymphomas with anti-idiotype antibodies alone and in combination with alpha interferon. Blood 1989;73:651-61.
5. Adamson TC III, Fox RI, Frisman DM, Howell FV. Immunohistologic analysis of lymphoid infiltrates in primary Sjögren's syndrome using monoclonal antibodies. J Immunol 1983;130:203-8.
6. Horsfall AC, Rose LM, Maini RN. Autoantibody synthesis in salivary glands of Sjögren's syndrome patients. J Autoimmun 1989;2:559-68.
7. Kizu Y, Sakurai H, Katagiri S, Shinozaki N, Ono M, Tsubota K, et al. Immunohistological analysis of tumor growth factor beta 1 expression in normal and inflamed salivary glands. J Clin Pathol 1996;49:728-32.
8. Stott DI, Hiepe F, Hummel M, Steinhauser G, Berek C. Antigen-driven clonal proliferation of B-cells within the target tissue of an autoimmune disease: the salivary glands of patients with Sjögren's syndrome. J Clin Invest 1998;102:938-46.
9. Price EJ, Venables PJW. The etiopathogenesis of Sjögren's syndrome. Semin Arthritis Rheum 1995;25:117-33.
10. Nusair S, Rubinow A. The use of oral pilocarpine in xerostomia and Sjögren's syndrome. Semin Arthritis Rheum 1999;28:360-7.
11. Tishler M, Yaron I, Shirazi I, Yaron M. Hydroxychloroquine treatment for primary Sjögren's syndrome: its effect on salivary and serum inflammatory markers. Ann Rheum Dis 1999;58:253-6.
12. Skopouli FN, Jagiello P, Tsifetaki N, Moutsopoulos HM. Methotrexate in primary Sjögren's syndrome. Clin Exp Rheumatol 1996;14:555-8.
13. Fox RI. Sjögren's syndrome: current therapies remain inadequate for a common disease. Expert Opin Investig Drugs 2000;9:2007-16.
14. Andoh Y, Shimura S, Sawai T, Sasaki H, Takishima T, Shirato K. Morphometric analysis of secretory glands in Sjögren's syndrome. Am Rev Respir Dis 1993;148:1358-62.
15. Shan D, Ledbetter JA, Press OW. Apoptosis of malignant human B-cells by ligation of CD20 with monoclonal antibodies. Blood 1998;91:1644-52.